MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
14.99%
Quick Ratio
11.17%
Cash Ratio
1.25%
Debt to Asset Ratio
659.35%
Unit: Dollar
Assets Breakdown
    • Total current assets
    • Operating right of use assets no...
    • Deposits and other receivables
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in-capital
    • Total current liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
466,503
149,789
256,357
308,460
Accounts receivable, net
2,397,736
2,932,899
1,578,269
2,099,065
Inventory note 3
1,425,002
1,341,295
1,974,758
2,256,289
Deposits and other receivables
1,306,801
1,432,501
1,171,855
872,420
Total current assets
5,596,042
5,856,484
4,981,239
5,536,234
Deposits and other receivables
112,322
109,297
109,297
109,297
Long-term accounts receivable
93,077
130,847
122,398
83,939
Property and equipment note 12
2,157
3,646
5,134
6,622
Operating right of use assets note 10
219,912
346,214
468,427
586,680
Total assets
6,023,510
6,446,488
5,686,495
6,322,772
Accounts payable and accrued liabilities note 4
9,301,716
8,970,870
8,532,932
7,908,201
Convertible promissory notes and short term loans note 5
10,971,841
11,114,209
11,145,852
10,394,614
Term loan, current note 6
14,834,983
14,680,914
2,400,000
2,400,000
Derivative liabilities note 8
450,328
445,893
432,782
443,583
Advance from customers
1,531,530
1,531,530
745,920
1,895,920
Operating lease obligations, current note 10
252,172
397,830
539,398
571,706
Total current liabilities
37,342,570
37,141,246
23,796,884
23,614,024
Federally guaranteed loans note 7
870,800
870,800
870,800
870,800
Term loan note 6
-
-
12,130,104
12,015,626
Derivative liabilities note 8
1,502,524
1,396,908
1,410,976
1,382,103
Operating lease obligations
-
-
-
102,307
Total liabilities
39,715,894
39,408,954
38,208,764
37,984,860
Series b convertible redeemable preferred stock, 0.001 and 0.001 par value, 600 and 600 shares authorized as of june 30, 2026 and march 31, 2026, respectively, 335 and 335 shares issued and outstanding as of june 30, 2026 and march 31, 2026, respectively note 9
1,714,476
1,714,476
1,714,476
-
Series b convertible redeemable preferred stock, 0.001 par value, 600 shares authorized as of september 30, 2025 and march 31, 2025, respectively, 360 and 385 shares issued and outstanding as of september 30, 2025 and march 31, 2025, respectively note 9-Series BConvertible Redeemable Preferred Stock
-
-
-
1,750,290
Preferred stock, value-Preferred Stocks
1
-
-
-
Preferred stock, value
-
1
1
1
Preferred stock, value-Series CPreferred Stock
2,433,002
-
-
-
Common stock, 0.001 and 0.001 par value, 125,000,000 and 125,000,000 shares authorized as at june 30, 2026 and march 31, 2026, respectively. issued and outstanding common shares 20,074,675 and 28,597,315 as at june 30, 2026 and march 31, 2026, respectively, and exchangeable shares of 160,672 and 160,672 outstanding as at june 30, 2026 and march 31, 2026, respectively note 9
20,237
28,759
27,969
26,953
Shares to be issued 581,599 and 1,005,815 shares of common stock as at june 30, 2026 and march 31, 2026, respectively note 9
279,428
284,668
284,244
284,244
Additional paid-in-capital
105,542,543
107,621,813
107,615,332
107,278,101
Accumulated other comprehensive loss
-41,518
-41,940
-47,823
-33,276
Accumulated deficit
-143,640,553
-142,570,243
-142,116,468
-140,968,401
Total stockholders (deficiency)
-35,406,860
-34,676,942
-34,236,745
-33,412,378
Total liabilities, mezzanine and stockholders deficiency
6,023,510
6,446,488
5,686,495
6,322,772
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$2,397,736 (28.86%↑ Y/Y)Inventory note 3$1,425,002 (-20.10%↓ Y/Y)Deposits and otherreceivables$1,306,801 (17.82%↑ Y/Y)Cash$466,503 (19.22%↑ Y/Y)Total current assets$5,596,042 (8.78%↑ Y/Y)Operating right of useassets note 10$219,912 (-68.64%↓ Y/Y)Deposits and otherreceivables$112,322 (2.77%↑ Y/Y)Long-term accountsreceivable$93,077 (25.46%↑ Y/Y)Property and equipmentnote 12$2,157 (-73.41%↓ Y/Y)Total assets$6,023,510 (-0.23%↓ Y/Y)Accumulated deficit-$143,640,553 (-2.46%↓ Y/Y)Accumulated othercomprehensive loss-$41,518 (-137.87%↓ Y/Y)Total liabilities,mezzanine and...$6,023,510 (-0.23%↓ Y/Y)Total stockholders(deficiency)-$35,406,860 (-7.95%↓ Y/Y)Additionalpaid-in-capital$105,542,543 (-1.34%↓ Y/Y)Preferred stock,value-Series CPreferred...$2,433,002 Shares to be issued581,599 and 1,005,815...$279,428 (-1.69%↓ Y/Y)Common stock, 0.001 and0.001 par value,...$20,237 (-24.29%↓ Y/Y)Preferred stock,value-Preferred Stocks$1 Total liabilities$39,715,894 (7.82%↑ Y/Y)Series b convertibleredeemable preferred...$1,714,476 Total currentliabilities$37,342,570 (71.25%↑ Y/Y)Derivative liabilitiesnote 8$1,502,524 (1.42%↑ Y/Y)Federally guaranteedloans note 7$870,800 (0.00%↑ Y/Y)Term loan, currentnote 6$14,834,983 (518.12%↑ Y/Y)Convertible promissorynotes and short term...$10,971,841 (8.80%↑ Y/Y)Accounts payable andaccrued liabilities...$9,301,716 (18.39%↑ Y/Y)Advance from customers$1,531,530 (222.04%↑ Y/Y)Derivative liabilitiesnote 8$450,328 (2.78%↑ Y/Y)Operating leaseobligations, current note 10$252,172 (-54.25%↓ Y/Y)

BIOTRICITY INC. (BTCY)

BIOTRICITY INC. (BTCY)